Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG CLASS:

PTK7-targeted antibody-drug conjugate

DRUG CLASS:

PTK7-targeted antibody-drug conjugate

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Related drugs:

‹

›

PTK7 expression	Non Small Cell Lung Cancer	PTK7 expression	Non Small Cell Lung Cancer	ABBV-647 Sensitive: C2 – Inclusion Criteria ABBV-647 Sensitive : C2	ABBV-647 Sensitive: C2 – Inclusion Criteria ABBV-647 Sensitive : C2
EGFR wild-type	Non Small Cell Lung Cancer	EGFR wild-type	Non Small Cell Lung Cancer	ABBV-647 Sensitive: C3 – Early Trials ABBV-647 Sensitive : C3	ABBV-647 Sensitive: C3 – Early Trials ABBV-647 Sensitive : C3
PTK7 expression + TROP2 expression	Triple Negative Breast Cancer	PTK7 expression + TROP2 expression	Triple Negative Breast Cancer	BCG033 Sensitive: D – Preclinical BCG033 Sensitive : D	BCG033 Sensitive: D – Preclinical BCG033 Sensitive : D
PTK7 expression + TROP2 expression	Solid Tumor	PTK7 expression + TROP2 expression	Solid Tumor	BCG033 Sensitive: D – Preclinical BCG033 Sensitive : D	BCG033 Sensitive: D – Preclinical BCG033 Sensitive : D
PTK7 expression	Triple Negative Breast Cancer	PTK7 expression	Triple Negative Breast Cancer	BCG033 Sensitive: D – Preclinical BCG033 Sensitive : D	BCG033 Sensitive: D – Preclinical BCG033 Sensitive : D